MedPath

To investigate the effect of methylprednisolone on inflammatory cytokines and urinary N-acetyl-beta-D-glucosaminidase/creatinine ratio in elective aortic aneurysm repair.

Phase 1
Conditions
Abdominal aortic aneurysm, unruptured.
Registration Number
EUCTR2005-000195-41-GB
Lead Sponsor
The Leeds Teaching Hospitals NHS Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

- Patients who are found to have an aortic aneurym larger than 6 cm diameter and who elect to undergo elective open surgical ( as opposed to radiological endovascular stenting) repair of the aneurysm.
- Males and Females
- Aged between 18 and 75 years
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

- Patients who have diabetes mellitus.
- Patients with an active proven bacterial or viral infection.
- Pre-existing cortico-steroid therapy.
- Systemic fungal infection.
- Acute renal failure or renal replacement therapy.
- Patients who are pregnant or lactating will be excluded.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath